Loading...
Market
Will Bavarian Nordic produce 10 million doses of mpox vaccine by December 31, 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official production reports from Bavarian Nordic
Story
Bavarian Nordic to Donate 40,000 Mpox Vaccine Doses; Shares Soared Thursday Amid Health Emergency
Aug 15, 2024, 11:25 AM
Danish biotech firm Bavarian Nordic announced it will donate 40,000 doses of its mpox vaccine to Africa's top public health body following the declaration of a health emergency. The World Health Organization (WHO) has declared the mpox outbreak in Africa a global health emergency, prompting a surge in the shares of vaccine makers like Bavarian Nordic. On Thursday, shares of these companies soared. Bavarian Nordic, one of the few with an approved mpox vaccine, is prepared to produce up to 10 million doses by 2025 to meet the immunization needs of African nations. The outbreak has led to increased efforts to mobilize resources to contain the virus.
View original story
Similar markets
Yes • 50%
No • 50%
Less than 1 million • 25%
1 to 3 million • 25%
3 to 5 million • 25%
More than 5 million • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Nigeria • 25%
Kenya • 25%
South Africa • 25%
Other • 25%
Less than 50,000 • 25%
50,000 to 99,999 • 25%
100,000 to 150,000 • 25%
More than 150,000 • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Moderna • 25%
Pfizer • 25%
AstraZeneca • 25%
Other • 25%
UK Government • 25%
Gavi • 25%
WHO • 25%
Other • 25%